OBJECTIVES: Timolol maleate has been reported to be a safer intraocular pressure (IOP) lowering treatment than latanoprost. The United States Food and Drug Administration approved latanoprostene bunod ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback